申请人:——
公开号:US20040234556A1
公开(公告)日:2004-11-25
A pharmaceutical aerosol formulation comprising a particulate medicament, one or more fluorocarbon or hydrogen-containing fluorocarbon propellants and a compound of the general formula (I) or a salt or solvate thereof, wherein A represents a straight chain C
1-16
alkylene substituted by n groups of formula B; n represents an integer 1 to 3; and B independently represents C
1-4
fluoroalkylC
0-6
alkylene-, C
1-4
fluoroalkylC
0-6
alkylene-O—, or C
1-4
alkylC
0-6
alkylene-O— wherein at least one substituent of formula B contains at least one fluorine atom and each C
1-4
fluoroalkyl- moiety contains one or more fluorine atoms but not more than 3 consecutive perfluorinated carbon atoms. The invention also extends to uses of compounds of formula (I) and certain novel compounds within the definition of formula (I).
1
一种制药气雾剂配方,包括颗粒状药物、一种或多种氟碳或含氢氟碳喷射剂和通式(I)的化合物或其盐或溶剂物,其中A代表被n个B式基团取代的直链C1-16烷基;n代表整数1至3;B独立地表示C1-4氟烷基C0-6烷基、C1-4氟烷基C0-6烷基-O-,或C1-4烷基C0-6烷基-O-,其中式B的至少一个取代基含有至少一个氟原子,每个C1-4氟烷基基团含有一个或多个氟原子,但不超过3个连续的全氟碳原子。本发明还涉及使用式(I)化合物和某些新颖的符合式(I)定义的化合物。